Stereotaxis, Inc.
St. Louis, Missouri medical robotics company (NYSE American: STXS) founded 1990; Genesis and GenesisX systems steer catheters magnetically for cardiac ablation.
Stereotaxis, Inc. is a publicly traded medical robotics company headquartered in St. Louis, Missouri, trading on NYSE American under the ticker STXS. Founded in 1990, the company developed Robotic Magnetic Navigation (RMN), using computer-controlled external magnets to steer flexible, magnetically tipped catheters through blood vessels for electrophysiology procedures such as catheter ablation for arrhythmias.
Its currently marketed platform is Genesis, built around compact rotating magnets on flexible robotic arms; GenesisX is a semi-mobile version installable in a catheterization lab over a weekend without shielding the room walls, since the magnetic field stays inside the system's base when parked. Stereotaxis pairs the navigation hardware with the Synchrony display, consolidating cath-lab systems onto one screen under a single keyboard and mouse, and with SynX, a cloud-based application for remote monitoring. The MAGiC catheter is a robotically navigated ablation catheter, and MAGiC Sweep is a high-density mapping catheter carrying 20 electrodes, not yet CE marked.
The predecessor Niobe RMN system was used in over 100,000 procedures at more than 100 hospitals worldwide before Stereotaxis moved its installed base toward Genesis, and the company continues pursuing magnetic-navigation applications beyond cardiac electrophysiology, including vascular and neurological procedures.
Primary type & automation activities this supplier delivers:
GenesisX Robotic Magnetic Navigation System
- Model: GenesisX
- Launch Year: 2025
Next-generation endovascular surgical robot using rotating magnets to steer catheters with sub-millimeter precision; FDA 510(k) cleared November 2025, self-shielded, operates on standard power.
Genesis RMN System
Robotic Magnetic Navigation system using flexible-arm-mounted rotating magnets to remotely steer magnetic catheters in cardiac electrophysiology procedures.
More related news
- 1
- 2
- 3
-
4
ISMR 2027: Medical Robotics Symposium, Nashville RobotToday · Oct 06, 2026
-
5
Robotics Summit & Expo 2027 | Jun 2–3, Boston RobotToday · Oct 05, 2026
- 6
- 7
- 8
- 9
- 10
-
11
Innovation Works Venture Expo 2026: 58 Pittsburgh Startups Pitch to Investors RobotToday · Sep 16, 2026
- 12
- 13
-
14
RobotToday Weekly Briefing August 31 – September 4, 2026 RobotToday · Sep 05, 2026
-
15
Robotics Investing: Intuitive Surgical or Unitree? RobotToday · Aug 31, 2026
-
16
ROBOTTODAY WEEKLY BRIEFING August 24 – 28, 2026 RobotToday · Aug 29, 2026
-
17
WRC 2026 Robot Systems: 149 Companies That Build Robots RobotToday · Aug 27, 2026
-
18
WRC 2026 Exhibitor Map: 248 Robotics Companies Mapped RobotToday · Aug 26, 2026
- 19
-
20
ROBOTTODAY Weekly July 13 – 17, 2026 RobotToday · Jul 18, 2026
Contact Stereotaxis, Inc.
WEBSITE
https://www.stereotaxis.com/HEADQUARTERS
United States
Company Facts
Founded
1990
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
Public
Funding Total
-
Certifications & Memberships
